BlackRock’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.2M | Sell |
2,613,281
-6,403
| -0.2% | -$46.7K | ﹤0.01% | 3079 |
|
|
2025
Q4 | $16.1M | Buy |
2,619,684
+55,040
| +2% | +$594K | ﹤0.01% | 3205 |
|
|
2025
Q3 | $47.3M | Sell |
2,564,644
-76,624
| -3% | -$1.23M | ﹤0.01% | 2540 |
|
|
2025
Q2 | $34.4M | Sell |
2,641,268
-118,702
| -4% | -$1.4M | ﹤0.01% | 2692 |
|
|
2025
Q1 | $29.2M | Sell |
2,759,970
-229,631
| -8% | -$3.64M | ﹤0.01% | 2715 |
|
|
2024
Q4 | $50.7M | Buy |
2,989,601
+37,588
| +1% | +$708K | ﹤0.01% | 2449 |
|
|
2024
Q3 | $68.5M | Buy |
2,952,013
+302,175
| +11% | +$6.46M | ﹤0.01% | 2291 |
|
|
2024
Q2 | $64.5M | Sell |
2,649,838
-93,164
| -3% | -$2.83M | ﹤0.01% | 2271 |
|
|
2024
Q1 | $92.6M | Buy |
2,743,002
+344,706
| +14% | +$12.2M | ﹤0.01% | 2097 |
|
|
2023
Q4 | $75.6M | Buy |
2,398,296
+260,596
| +12% | +$6.19M | ﹤0.01% | 2247 |
|
|
2023
Q3 | $54.6M | Buy |
2,137,700
+145,465
| +7% | +$4.48M | ﹤0.01% | 2350 |
|
|
2023
Q2 | $57.1M | Buy |
1,992,235
+195,918
| +11% | +$5.33M | ﹤0.01% | 2401 |
|
|
2023
Q1 | $43.1M | Sell |
1,796,317
-88,568
| -5% | -$1.59M | ﹤0.01% | 2549 |
|
|
2022
Q4 | $32M | Sell |
1,884,885
-75,704
| -4% | -$1.32M | ﹤0.01% | 2768 |
|
|
2022
Q3 | $29.1M | Buy |
1,960,589
+56,287
| +3% | +$945K | ﹤0.01% | 2822 |
|
|
2022
Q2 | $30M | Buy |
1,904,302
+208,663
| +12% | +$4.09M | ﹤0.01% | 2851 |
|
|
2022
Q1 | $45.7M | Sell |
1,695,639
-63,951
| -4% | -$1.63M | ﹤0.01% | 2642 |
|
|
2021
Q4 | $65.1M | Buy |
1,759,590
+38,882
| +2% | +$1.58M | ﹤0.01% | 2480 |
|
|
2021
Q3 | $82.2M | Buy |
1,720,708
+17,199
| +1% | +$771K | ﹤0.01% | 2336 |
|
|
2021
Q2 | $57.6M | Sell |
1,703,509
-49,095
| -3% | -$1.66M | ﹤0.01% | 2603 |
|
|
2021
Q1 | $72.4M | Sell |
1,752,604
-29,351
| -2% | -$1.75M | ﹤0.01% | 2381 |
|
|
2020
Q4 | $77.3M | Buy |
1,781,955
+619,727
| +53% | +$42M | ﹤0.01% | 2228 |
|
|
2020
Q3 | $49.9M | Buy |
1,162,228
+198,866
| +21% | +$9.87M | ﹤0.01% | 2305 |
|
|
2020
Q2 | $45M | Buy |
963,362
+887,938
| +1,177% | +$30.6M | ﹤0.01% | 2313 |
|
|
2020
Q1 | $1.03M | Buy |
75,424
+12,330
| +20% | +$158K | ﹤0.01% | 3862 |
|
|
2019
Q4 | $686K | Buy |
63,094
+544
| +0.9% | +$5.69K | ﹤0.01% | 4101 |
|
|
2019
Q3 | $643K | Buy |
62,550
+39,002
| +166% | +$422K | ﹤0.01% | 4107 |
|
|
2019
Q2 | $222K | Buy |
23,548
+4,480
| +23% | +$32.9K | ﹤0.01% | 4345 |
|
|
2019
Q1 | $130K | Sell |
19,068
-1,302
| -6% | -$6.66K | ﹤0.01% | 4333 |
|
|
2018
Q4 | $92K | Sell |
20,370
-372
| -2% | -$2.29K | ﹤0.01% | 4368 |
|
|
2018
Q3 | $183K | Buy |
20,742
+837
| +4% | +$6.97K | ﹤0.01% | 4334 |
|
|
2018
Q2 | $169K | Buy |
+19,905
| New | +$129K | ﹤0.01% | 4347 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
